SYK Inhibitor Drugs: Expanding the Therapeutic Landscape for Autoimmune Diseases
SYK inhibitor drugs represent a promising class of targeted therapies, with fostamatinib leading the way in the treatment of immune thrombocytopenia (ITP). SYK inhibitor drugs like fostamatinib offer a novel mechanism for immune thrombocytopenia treatment by targeting the spleen tyrosine kinase pathway, which is critical in immune cell signaling. The global market for fostamatinib...
0 Comentários 0 Compartilhamentos 2 Visualizações 0 Anterior